• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET,EA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET,EA Back to Search Results
Catalog Number 10220
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 09/14/2020
Event Type  Death  
Manufacturer Narrative
Lot number and expiry are not available at this time.Investigation: per the customer, the replacement fluid used was fresh frozen plasma.A terumo bct service technician performed a service check on the device.The service technician replaced a defective replacement fluid sensor.An autotest and saline run were successfully performed.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer called because they had noticed discolored plasma as soon as they connected the patient with thrombotic thrombocytopenia pupura (ttp) for a therapeutic plasma exchange procedure.Then, 20 minutes into the procedure, they started to see hemolysis in the remove bag and connector.The patient's doctor ordered rinseback and to discontinue the procedure.The patient was stable with normal vital signs and the doctor was going to consult with a hematologist regarding reason for the hemolysis.Upon follow up, the customer reported that the hemolysis was determined to be due to disease state.The customer stated that the patient had expired on (b)(6) 2020.Per the customer, cause of death was the patient's disease, determined by the doctor and the patient did not passed during or after the tpe procedure.No autopsy report is available.The customer declined to provide patient age, weight, and gender.Patient identifier is not available at this time.This report is being filed due to patient death, though at this time there is not an allegation that the device caused or contributed to the patient death.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: the run data file was analyzed for this event.Analysis of run data file indicated the device operated as intended and is safe to use.The automated interface management(aim)system images were clean and clear and the lighting was in the appropriate range as well.Run summary: actual fluid balance: 107 ml (102%) procedure time: 27 min saline to patient: 87 ml ac to patient: 32 ml rinseback was completed total plasma removed: 686 ml replacement plasma used: 662 ml received alarm(s): x4 "cells were detected in the plasma line from the centrifuge" and x1 "confirming selection to disable rbc detector" the customer did not provide the lot number pertaining to this event, therefore a device history record (dhr) search could not be conducted for this specific incident.All lots must meet acceptance criteria before release.Per internal medical review and analysis, the device did not cause or contribute to this incident.Root cause: based on the physician's statements, supported by the clinical findings, rdf analysis, the service performed on the device, the cause of the patient's death was due to the patient's medical condition.The plasma free hemoglobin contents in the patient's plasma triggered 'cells were detected in plasma line from centrifuge' alarms.Based on the physician's statements, the cause of hemolysis was related to the disease progression of the ttp.Based on the clinical and investigation findings, there is no evidence to suggest that malfunction or user error of the spectra optia device or optia disposables caused or contributed to the patient's death.Based on the physician's statements reported to the terumo bct customer support representative and investigation of this event, the cause of the patient's death was likely due to their underlying medical condition.
 
Event Description
Patient sex and weight were obtained from the run data file.
 
Manufacturer Narrative
This report is being filed to provide additional information in b.5.
 
Event Description
The customer declined to provide the patient identifier.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET,EA
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key10635386
MDR Text Key210006705
Report Number1722028-2020-00457
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 10/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number10220
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Manufacturer Received03/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Weight76
-
-